Orphan Drugs Finding Home In Markets: Could Be 20% Of All Sales By 2020 15/07/2016 by Intellectual Property Watch 2 Comments Worldwide sales for orphan drugs are forecast to reach $178 billion by 2020, according to a recent industry report. Moreover, the orphan drug market is expected to grow almost 12 percent per year, a level the broader pharmaceutical market “could only dream about” with its expected annual growth of 5.9 percent, according to Lisa Urquhart, editor of EvaluatePharma Vantage.
New Book On Price-Reducing Strategies For Essential Medicines Under IPRs 13/07/2016 by Intellectual Property Watch 1 Comment A new book and website examine the impact of intellectual property rights on access to new essential medicines and call for measures that were used to reduce prices of patented HIV medicines to be applied in the case of essential medicines.
CopyCamp 2016 Open Call 12/07/2016 by Intellectual Property Watch Leave a Comment The Modern Poland Foundation is pleased to launch an Open Call for Speakers at the 5th International CopyCamp Conference (October 27-28, 2016 in Warsaw).
Generic Manufacturing Deals For HIV And Hepatitis C Treatments Signed At Medicines Patent Pool 07/07/2016 by Intellectual Property Watch Leave a Comment Today the Medicines Patent Pool announced the signing of nine new sub-licensing agreements for the generic manufacturing of key HIV and hepatitis C treatments.
New Book: Ways To Address CBD, Nagoya Protocol Hurdles For Public Research 04/07/2016 by Intellectual Property Watch 1 Comment A new book provides ways for public research to avoid legal battles over genetic resources in the fields of agriculture, biomedicine, environmental management and microbiology by making best use of an international protocol on access to genetic resources and benefit-sharing.
National Parliaments Not Needed For CETA Approval, European Commission President Juncker Says 29/06/2016 by Intellectual Property Watch 5 Comments European Commission President Jean-Claude Juncker said today that the European Union would not include national parliaments of EU member states in the final decision on the Canada-EU Trade Agreement (CETA). Juncker’s CETA statement was made during the post-Brexit meeting of EU heads of state in Brussels today (28 June), several German newspapers reported quoting the German News Agency (DPA).
WHO Names New Head Of Health Emergencies 28/06/2016 by Intellectual Property Watch 1 Comment The World Health Organization has named veteran health crisis expert Peter Salama of Australia the next head of the Health Emergencies Programme, a high-profile position for the UN agency’s leadership against outbreaks and disasters.
WHO/PAHO New Response Plan For Zika Until December 2017 17/06/2016 by Intellectual Property Watch Leave a Comment A new response plan for a strategic response to the Zika virus has been announced by the World Health Organization and the Pan American Health Organization.
European Council Conclusions On Steps To Combat Antimicrobial Resistance 17/06/2016 by Intellectual Property Watch 1 Comment The 28 European Union member governments have concluded next steps for addressing antimicrobial resistance, with a strong emphasis on reducing use of antibiotics in animals, but also including a call for new business models.
Generics, Biosimilars Makers Join Global Medical Harmonisation Body 15/06/2016 by Intellectual Property Watch 1 Comment Doors to a global medical harmonisation organisation opened to the generic and biosimilar industry, which described it as an historical moment for them. The industry will now be able to sit on the assembly of the international body that joins regulators with the pharmaceutical industry.